Novo Nordisk A/S has initiated a share repurchase program on May 6, 2024, to buy back B shares for up to DKK 2.2 billion from May 7 to August 5, 2024. As of July 19, 2024, they have repurchased a total of 10,619,037 shares at an average price of DKK 878.31, spending DKK 9.3 billion thus far.